Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Lockheed Martin Corporation (LMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Lockheed Martin Corporation — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Lockheed Martin Corporation trades at $525.88 (market cap $120.53B). The key difference: Lockheed Martin Corporation is far larger — about 3.9× GE HealthCare Technologies Inc. Common Stock's market cap, and Lockheed Martin Corporation pays the higher dividend (2.76%). Which is the better fit depends on your goals.
| GEHC | LMT | |
|---|---|---|
Market Cap | $30.93B | $120.53B |
Volume | 5,033,451 | 1,477,073 |
Sector | Health | Industrials |
52-Week High | $88.16 | $676.70 |
52-Week Low | $59.48 | $439.19 |
Enterprise Value | $39.39B | $137.27B |
Dividend Yield | 0.23% | 2.76% |
Typical Hold Time | — | 86 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Lockheed Martin (LMT) trades at $504.02, down 1.54% on the day, with a bearish technical signal despite strong analyst support. The company reported mixed quarterly earnings with two misses and one beat, while maintaining robust cash flow generation and a 23-year dividend growth streak. Recent news highlights strategic AI partnerships and F-35 program developments.
LMT offers attractive valuation metrics with a P/E of 18.58 and strong analyst consensus pointing to 24% upside to the $625.64 price target. However, execution risks on fixed-price contracts and recent earnings volatility warrant caution despite the company's dominant defense contracting position and stable government funding.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →
